Schedule 13G ownership disclosure

4D PHARMA PLC

Security class unavailable · CUSIP: 35085K109

Event date: 2022-02-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,395,000
Percent of class
1.3300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-22-029409
Form type
SC 13G/A
Filer
4D Pharma PLC
CIK
CIK 1830162
Filed
Mar 02, 2022
Reporting period
Feb 23, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub